ESHRE Virtual 36th Annual Meeting

No benefit to endometrial scratching before first-cycle IVF/ICSI

Roshini Claire Anthony, 20200911200001

Endometrial scratching prior to first cycle of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI) has no benefit on livebirth or clinical pregnancy rate, according to a study presented at ESHRE 2020.

Relugolix combo therapy could reduce HMB-related anaemia, distress

Roshini Claire Anthony, 20200813200002

Relugolix combination therapy (relugolix-CT) comprising relugolix and estradiol (E2)/norethindrone acetate (NETA) could improve anaemia in women with heavy menstrual bleeding (HMB) due to uterine fibroids, according to pooled results of the phase III LIBERTY* 1 and 2 trials presented at ESHRE 2020.

Emotion-focused strategies may help women cope with recurrent pregnancy loss

Audrey Abella, 20200812100000

Meditation and mindfulness interventions may reduce perceived stress in women who had recurrent pregnancy loss (RPL; ie, ≥3 consecutive losses), according to data presented at ESHRE 2020.

Cerebral palsy risk in IVF babies halved in past 20 years

Pearl Toh, 20200810150010

The incidence of cerebral palsy among children conceived through in vitro fertilization (IVF) has been halved over the past two decades, although the risk of cerebral palsy remains higher than children who are conceived naturally, according to a Nordic study presented at the ESHRE 2020 Meeting.

BEACOPP de-escalation may reduce ovarian insufficiency in women with Hodgkin lymphoma

Audrey Abella, 20200807100000

De-escalating the BEACOPPescalated* regimen through a PET-driven strategy may reduce the risk of acute premature ovarian insufficiency (POI) in women with newly diagnosed advanced Hodgkin lymphoma (HL), subanalysis results of the phase III AHL2011 trial have shown.

Freeze-only embryo transfer may improve developmental outcomes in offspring

Elaine Soliven, 20200805000000

Children who were born after freeze-only embryo transfer (ET) experienced improved early developmental outcomes, particularly problem solving and fine motor skills, than those who were born after fresh ET, according to a follow-up study presented at ESHRE 2020.

Fertility preservation vital in female cancer survivors

Roshini Claire Anthony, 20200804200001

Female cancer survivors who undergo fertility preservation before cancer treatment often use their stored gametes/embryos. This highlights the effectiveness of pre-cancer fertility preservation, according to a study presented at ESHRE 2020.

Rucaparib trumps chemo for relapsed, advanced BRCA+ ovarian cancer

Low ovarian reserve a marker of later health problems?

Pearl Toh, 20200731181000

Early ovarian ageing may be predictive of later health problems, suggests a large cohort study presented at the 2020 ESHRE Meeting.

Linzagolix reduces HMB in women with uterine fibroids

Elaine Soliven, 20200727000000

The use of linzagolix, a new oral gonadotropin-releasing hormone (GnRH) antagonist, with or without add-back therapy (ABT) significantly reduces heavy menstrual bleeding (HMB) in women with uterine fibroids, according to the PRIMROSE 2* trial presented at ESHRE 2020.